Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 Zika vaccine in healthy adults
NCT04015648Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Oct 2019
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial of ChAdOx1 Zika in Zika virus infection, sponsored by University of Oxford. Primary endpoint: Solicited Adverse Events at 7 days. Started Oct 2019; status: completed.
02
Drugs
ChAdOx1 Zika
03
Conditions
Zika virus infection
Beyond the preview
Go deeper on NCT04015648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04015648.